Since the introduction of docetaxel, research has focused on various approaches to overcome treatment limitations and improve outcome. This review discusses the pharmacological attempts at treatment optimisation, which include reducing interindividual pharmacokinetic and pharmacodynamic variability, optimising schedule, route of administration, reversing drug resistance and the development of structurally related second-generation taxanes.

, , ,
doi.org/10.1038/sj.bjc.6602698, hdl.handle.net/1765/70727
British Journal of Cancer
Erasmus MC: University Medical Center Rotterdam

Engels, F., Sparreboom, A., Mathot, R., & Verweij, J. (2005). Potential for improvement of docetaxel-based chemotherapy: A pharmacological review. British Journal of Cancer (Vol. 93, pp. 173–177). doi:10.1038/sj.bjc.6602698